Renal Impairment Linked to Worse Prognosis in IgD Multiple Myeloma
TUESDAY, Dec. 20, 2022 (HealthDay News) — For patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no-RI), according to a stu…
Learn MoreAntibody Treatment Makes Inroads Against Multiple Myeloma
MONDAY, Dec. 12, 2022 (HealthDay News) — An experimental immunotherapy appears highly effective in attacking bone marrow cancer, with nearly three in four patients responding to the treatment, new clinical trial results show.The drug, talquetamab, wo…
Learn MoreSignificant Treatment Attrition Rate Seen in Multiple Myeloma
TUESDAY, Nov. 22, 2022 (HealthDay News) — There is a significant treatment attrition rate in newly diagnosed multiple myeloma (NDMM), according to a study published in the November issue of Leukemia & Lymphoma.Victor H. Jimenez-Zepeda, M.D., from Alb…
Learn MoreOptions Explored for MM That Relapses After BCMA CAR T Therapy
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — Patients with multiple myeloma that relapses after B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell (CAR T) therapy can potentially be treated with multiple lines of salvage therapy…
Learn MorePhoton-Counting Detector CT Helps ID Multiple Myeloma Lesions
MONDAY, Sept. 19, 2022 (HealthDay News) — Photon-counting detector (PCD) computed tomography (CT) with deep learning noise reduction may improve spatial resolution for viewing findings in multiple myeloma compared with energy-integrating detector (EI…
Learn MoreT-Cell Redirection Therapy Studied for Relapsed Multiple Myeloma
THURSDAY, Sept. 15, 2022 (HealthDay News) — In patients with heavily pretreated relapsed/refractory multiple myeloma with relapse after bispecific antibody (BiAb) T-cell redirection therapy, subsequent T-cell redirection therapy is feasible as salvag…
Learn MoreRisk for MGUS Up in WTC-Exposed Rescue/Recovery Workers
THURSDAY, Sept. 8, 2022 (HealthDay News) — World Trade Center (WTC)-exposed rescue/recovery workers have an increased risk for the myeloma precursor disease monoclonal gammopathy of undetermined significance (MGUS), according to a study published o…
Learn MorePolypharmacy Prevalent Among Older Adults With Blood Cancers
THURSDAY, Aug. 11, 2022 (HealthDay News) — For older adults with blood cancers, taking eight or more medications is associated with frailty, according to a study published in the August issue of the Journal of the National Comprehensive Cancer Netw…
Learn MoreCaregivers of Multiple Myeloma Patients Face Mental Health Issues
TUESDAY, Aug. 2, 2022 (HealthDay News) — Many caregivers of patients with multiple myeloma (MM) report mental health challenges, according to a study published online July 18 in Blood Advances.Elizabeth K. O’Donnell, M.D., from the Massachusetts Gene…
Learn MoreA-Fib Linked to Worse Hospital Outcomes in Multiple Myeloma
WEDNESDAY, July 20, 2022 (HealthDay News) — Overall, 13.1 percent of hospitalized patients with multiple myeloma (MM) have atrial fibrillation, which is associated with worse outcomes, according to a study recently published in Cureus.Inimfon Jackson…
Learn More